AngioDynamics, Inc.
http://www.angiodynamics.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From AngioDynamics, Inc.
Minute Insight: Merit Adds Dialysis and Biopsy Products For $132.5m
The Utah company acquired dialysis and biopsy devices from AngioDynamics for $100m and an access catheter from Bluegrass Vascular for $32.5m.
Jury Backs C.R. Bard In AngioDynamics Antitrust Case
A New York jury found for C.R. Bard in an antitrust case brought by competitor AngioDynamics, who said that the way Bard packaged its catheter tip location systems preloaded into central lines was anti-competitive.
Medtechs Drive To Keep The Status Quo In A Year Like No Other
The performances of the leading medtechs in the first year of the COVID-19 pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management skills and planning.
MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other
The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.
Company Information
- Industry
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
-
- Eximo Hybrid Medical Technologies
- Eximo Medical Ltd.
- Flowmedica
- Microsulis Medical Ltd.
- Navilyst Medical
- Radiadyne
- Vortex Meidcal, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice